New Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MD

In every episode of New Insight, Veeral Sheth, MD, Director of Clinical Trials at University Retina in Chicago, takes an in-depth look at the biggest news in ophthalmology and the behind the scenes work involved in eye care, with a rotation of guest experts involved in ophthalmic research, development, and clinical care. The latest episode of New Insight features a conversation with Ocuphire Pharma’s CEO on the company’s flagship retinal product and leading a small, but high-powered research team. Episode Highlights: 0:04 Introduction1:23 History of Ocuphire Pharma3:50 Leading a small, high-functioning team6:41 Magrath’s background and journey 11:02 APX3330 for Diabetic Retinopathy15:20 2024 Plans for Ocuphire18:53 Addressing unmet needs20:20 OutroEvery episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at [email protected].